000290588 001__ 290588
000290588 005__ 20241126132219.0
000290588 0247_ $$2doi$$a10.1007/s00761-024-01501-6
000290588 0247_ $$2ISSN$$a2731-7226
000290588 0247_ $$2ISSN$$a0947-8965
000290588 0247_ $$2ISSN$$a1433-0415
000290588 0247_ $$2ISSN$$a2731-7234
000290588 037__ $$aDKFZ-2024-01185
000290588 041__ $$aGerman
000290588 082__ $$a610
000290588 1001_ $$0P:(DE-He78)2c984a7f2206879886962a4375764178$$aBlickle, Patricia$$b0$$eFirst author$$udkfz
000290588 245__ $$aAssessment and treatment of cancer-related fatigue.[Erfassung und Behandlung krebsassoziierter Fatigue.]
000290588 260__ $$aNew York$$bSpringer Medizin$$c2024
000290588 3367_ $$2DRIVER$$aarticle
000290588 3367_ $$2DataCite$$aOutput Types/Journal article
000290588 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1718886169_15770
000290588 3367_ $$2BibTeX$$aARTICLE
000290588 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000290588 3367_ $$00$$2EndNote$$aJournal Article
000290588 500__ $$a#EA:C110#LA:C110# / Volume 30, pages 548–555, (2024) 
000290588 520__ $$aBackground: Cancer-related fatigue is a common and complex symptom that can significantly affect patients' quality of life. During active treatment, up to 90% of patients suffer from fatigue. Even years after treatment, up to one third of survivors are affected by persistent fatigue. The current care situation in Germany is unsatisfactory. Objective: This article aims to highlight the complexity of fatigue and the importance of assessing and treating this symptom. Materials and methods: Based on existing international guidelines, different ways of assessing fatigue and different treatment approaches are presented. Results: A thorough medical history is essential to identify early targets for prevention and treatment of fatigue. Regular screening and comprehensive education of all patients and their relatives play an important role in this regard. As screening and education are still insufficient, many patients do not have access to effective treatments. At the intervention level, physical activity, exercise, yoga, and psychosocial programs have been shown to be very effective. Drug therapy is currently not recommended. Conclusion: The assessment and management of fatigue is complex and requires multiprofessional teams. As sufficient care structures for the treatment of fatigue do not yet exist in Germany, providing comprehensive information about the symptom and regular screening are particularly important.
000290588 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000290588 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000290588 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b1$$udkfz
000290588 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b2$$eLast author$$udkfz
000290588 773__ $$0PERI:(DE-600)3120761-3$$a10.1007/s00761-024-01501-6$$p548–555$$tDie Onkologie$$v30$$x2731-7226$$y2024
000290588 8564_ $$uhttps://inrepo02.dkfz.de/record/290588/files/s00761-024-01501-6.pdf
000290588 8564_ $$uhttps://inrepo02.dkfz.de/record/290588/files/s00761-024-01501-6.pdf?subformat=pdfa$$xpdfa
000290588 909CO $$ooai:inrepo02.dkfz.de:290588$$pVDB
000290588 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2c984a7f2206879886962a4375764178$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000290588 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000290588 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000290588 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000290588 9141_ $$y2024
000290588 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-27$$wger
000290588 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-27$$wger
000290588 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONKOLOGIE-GER : 2022$$d2023-10-27
000290588 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-27
000290588 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000290588 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000290588 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000290588 980__ $$ajournal
000290588 980__ $$aVDB
000290588 980__ $$aI:(DE-He78)C110-20160331
000290588 980__ $$aUNRESTRICTED